| Classifying Cancers Based on T-cell Infiltration and PD-L1 | Cancer Research | 2015 | 864 |
| Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial | Annals of Oncology | 2014 | 780 |
| Translational biology of osteosarcoma | Nature Reviews Cancer | 2014 | 644 |
| Targeting natural killer cells in cancer immunotherapy | Nature Immunology | 2016 | 628 |
| Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance | Immunity | 2013 | 609 |
| Type I interferons in anticancer immunity | Nature Reviews Immunology | 2015 | 606 |
| Combination cancer immunotherapies tailored to the tumour microenvironment | Nature Reviews Clinical Oncology | 2016 | 561 |
| Consensus guidelines for the detection of immunogenic cell death | OncoImmunology | 2014 | 524 |
| Cancer immunoediting and resistance to T cell-based immunotherapy | Nature Reviews Clinical Oncology | 2019 | 518 |
| IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases | Nature Medicine | 2015 | 488 |
| Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells | Clinical Cancer Research | 2013 | 485 |
| Immunobiology of human cytomegalovirus: from bench to bedside | Clinical Microbiology Reviews | 2009 | 444 |
| Clinical relevance of host immunity in breast cancer: from TILs to the clinic | Nature Reviews Clinical Oncology | 2016 | 429 |
| Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments | Lancet Infectious Diseases, The | 2004 | 415 |
| A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus | Nature Biotechnology | 2006 | 403 |
| Modulating the stem cell niche for tissue regeneration | Nature Biotechnology | 2014 | 392 |
| Schistosomiasis | Nature Reviews Disease Primers | 2018 | 361 |
| Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease | Cancer Discovery | 2016 | 356 |
| Current status of vaccines for schistosomiasis | Clinical Microbiology Reviews | 2008 | 349 |
| Control of Metastasis by NK Cells | Cancer Cell | 2017 | 338 |
| Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells | Nature Immunology | 2017 | 330 |
| Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis | Nature Medicine | 2006 | 317 |
| Resistance to PD1/PDL1 checkpoint inhibition | Cancer Treatment Reviews | 2017 | 305 |
| Targeting immunosuppressive adenosine in cancer | Nature Reviews Cancer | 2017 | 304 |
| Classification of current anticancer immunotherapies | Oncotarget | 2014 | 301 |
